Works matching IS 00071048 AND DT 2013 AND VI 161 AND IP 3


Results: 24
    1
    2
    3

    Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 434, doi. 10.1111/bjh.12265
    By:
    • Gruson, Bérengère;
    • Lortholary, Olivier;
    • Canioni, Danielle;
    • Chandesris, Olivia;
    • Lanternier, Fanny;
    • Bruneau, Julie;
    • Grosbois, Bernard;
    • Livideanu, Cristina;
    • Larroche, Claire;
    • Durieu, Isabelle;
    • Barete, Stéphane;
    • Sevestre, Henri;
    • Diouf, Momar;
    • Chaby, Guillaume;
    • Marolleau, Jean‐Pierre;
    • Dubreuil, Patrice;
    • Hermine, Olivier;
    • Damaj, Gandhi
    Publication type:
    Article
    4
    5
    6

    Corrigendum.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 457, doi. 10.1111/bjh.12312
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    R- CHOP therapy alone in limited stage diffuse large B-cell lymphoma.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 383, doi. 10.1111/bjh.12281
    By:
    • Tomita, Naoto;
    • Takasaki, Hirotaka;
    • Miyashita, Kazuho;
    • Fujisawa, Shin;
    • Ogusa, Eriko;
    • Matsuura, Shiro;
    • Kishimoto, Kumiko;
    • Numata, Ayumi;
    • Fujita, Atsuko;
    • Ohshima, Rika;
    • Kuwabara, Hideyuki;
    • Hagihara, Maki;
    • Hashimoto, Chizuko;
    • Takemura, Sachiya;
    • Koharazawa, Hideyuki;
    • Yamazaki, Etsuko;
    • Fujimaki, Katsumichi;
    • Taguchi, Jun;
    • Sakai, Rika;
    • Ishigatsubo, Yoshiaki
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 339, doi. 10.1111/bjh.12256
    By:
    • Lee, Yun‐Gyoo;
    • Kim, Inho;
    • Yoon, Sung‐Soo;
    • Park, Seonyang;
    • Cheong, June Won;
    • Min, Yoo Hong;
    • Lee, Jeong‐Ok;
    • Bang, Soo‐Mee;
    • Yi, Hyeon Gyu;
    • Kim, Chul Soo;
    • Park, Yong;
    • Kim, Byung‐Soo;
    • Mun, Yeung‐Chul;
    • Seong, Chu‐Myoung;
    • Park, Jinny;
    • Lee, Jae Hoon;
    • Kim, Sung‐Yong;
    • Lee, Hong Ghi;
    • Kim, Yeo‐Kyeoung;
    • Kim, Hyeoung‐Joon
    Publication type:
    Article
    21
    22
    23

    A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 357, doi. 10.1111/bjh.12266
    By:
    • Voorhees, Peter M.;
    • Manges, Robert F.;
    • Sonneveld, Pieter;
    • Jagannath, Sundar;
    • Somlo, George;
    • Krishnan, Amrita;
    • Lentzsch, Suzanne;
    • Frank, Richard C.;
    • Zweegman, Sonja;
    • Wijermans, Pierre W.;
    • Orlowski, Robert Z.;
    • Kranenburg, Britte;
    • Hall, Brett;
    • Casneuf, Tineke;
    • Qin, Xiang;
    • Velde, Helgi;
    • Xie, Hong;
    • Thomas, Sheeba K.
    Publication type:
    Article
    24